SCM
ZURA icon

Superstring Capital Management’s Zura Bio ZURA Stock Holding History

Superstring Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-186,943
Closed -$467K – 51
2024
Q4 		$467K Buy
186,943
+30,317
+19% +$108K 0.4% 33
2024
Q3 		$636K Hold
156,626
– – 0.56% 22
2024
Q2 		$548K Buy
+156,626
New +$638K 0.69% 29

Other funds holding ZURA

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Superstring Capital Management's ZURA Position: Q1 2025 in Review

Superstring Capital Management sold out of Zura Bio (ZURA) in Q1 2025, closing a stake of 186,943 shares — an estimated $467K sold.

Superstring Capital Management first reported a position in ZURA in Q2 2024 and held it in 3 quarters. The position peaked at $636K in Q3 2024. 74 funds tracked by Wall St. Rank hold ZURA as of Q1 2025.

  • Superstring Capital Management reported no remaining Zura Bio position as of Q1 2025 after selling out during the quarter.
  • Superstring Capital Management sold 186,943 Zura Bio shares in Q1 2025, an estimated $467K.
  • Superstring Capital Management first reported a position in Zura Bio in Q2 2024 and held it in 3 quarters.
  • Superstring Capital Management's Zura Bio position peaked at $636K in Q3 2024.
  • 74 funds tracked by Wall St. Rank held Zura Bio as of Q1 2025.

Based on Superstring Capital Management's 13F filing for Q1 2025, filed 15 May 2025.